The global Recombinant Human PDGF-BB Protein market size was valued at US$ 115 million in 2024 and is forecast to a readjusted size of USD 194 million by 2031 with a CAGR of 7.8% during review period.
Platelet-derived growth factor (PDGF) was discovered as a major mitogenic factor present in serum but absent from plasma. In vitro, PDGF-BB stimulated MAP kinase activity and cell motility of isolated lymphatic endothelial cells. In vivo, PDGF-BB potently induced growth of lymphatic vessels. Expression of PDGF-BB in murine fibrosarcoma cells induced tumor lymphangiogenesis, leading to enhanced metastasis in lymph nodes. The PDGF signaling system contributes to and vascular remodeling. Growth factors such as PDGF exert potent effects on wound healing including the regeneration of tooth-supporting structures.
This report is a detailed and comprehensive analysis for global Recombinant Human PDGF-BB Protein market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Recombinant Human PDGF-BB Protein market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Recombinant Human PDGF-BB Protein market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Recombinant Human PDGF-BB Protein market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Recombinant Human PDGF-BB Protein market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Human PDGF-BB Protein
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Human PDGF-BB Protein market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Bio-Techne, Scientists Helping Scientists, Abcam Limited, FUJIFILM Irvine Scientific, BD Biosciences, Bio-Rad Laboratories, Inc., BPS Bioscience, Inc., Elabscience, Yisheng Biotechnology (Shanghai) Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Âé¶¹Ô´´ Segmentation
Recombinant Human PDGF-BB Protein market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Âé¶¹Ô´´ segment by Type
±Ê³Ü°ù¾±³Ù²â<95%
Purity ≥95%
Âé¶¹Ô´´ segment by Application
University
Research Center
Major players covered
Thermo Fisher Scientific Inc.
Bio-Techne
Scientists Helping Scientists
Abcam Limited
FUJIFILM Irvine Scientific
BD Biosciences
Bio-Rad Laboratories, Inc.
BPS Bioscience, Inc.
Elabscience
Yisheng Biotechnology (Shanghai) Co., Ltd.
Abbkine
Beijing Biocreative Technology Co., Ltd.
Shanghai Yaji Biotechnology Co., Ltd.
Cellverse Co., Ltd.
Dalian Meilun Biotech Co., Ltd.
Sino Biological,Inc.
Prospec-Tany Technogene Ltd
ENZO
Âé¶¹Ô´´ segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Human PDGF-BB Protein product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Human PDGF-BB Protein, with price, sales quantity, revenue, and global market share of Recombinant Human PDGF-BB Protein from 2020 to 2025.
Chapter 3, the Recombinant Human PDGF-BB Protein competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Human PDGF-BB Protein breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Recombinant Human PDGF-BB Protein market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Human PDGF-BB Protein.
Chapter 14 and 15, to describe Recombinant Human PDGF-BB Protein sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Âé¶¹Ô´´ Overview
1.1 Product Overview and Scope
1.2 Âé¶¹Ô´´ Estimation Caveats and Base Year
1.3 Âé¶¹Ô´´ Analysis by Type
1.3.1 Overview: Global Recombinant Human PDGF-BB Protein Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 ±Ê³Ü°ù¾±³Ù²â<95%
1.3.3 Purity ≥95%
1.4 Âé¶¹Ô´´ Analysis by Application
1.4.1 Overview: Global Recombinant Human PDGF-BB Protein Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 University
1.4.3 Research Center
1.5 Global Recombinant Human PDGF-BB Protein Âé¶¹Ô´´ Size & Forecast
1.5.1 Global Recombinant Human PDGF-BB Protein Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Recombinant Human PDGF-BB Protein Sales Quantity (2020-2031)
1.5.3 Global Recombinant Human PDGF-BB Protein Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific Inc.
2.1.1 Thermo Fisher Scientific Inc. Details
2.1.2 Thermo Fisher Scientific Inc. Major Business
2.1.3 Thermo Fisher Scientific Inc. Recombinant Human PDGF-BB Protein Product and Services
2.1.4 Thermo Fisher Scientific Inc. Recombinant Human PDGF-BB Protein Sales Quantity, Average Price, Revenue, Gross Margin and Âé¶¹Ô´´ Share (2020-2025)
2.1.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
2.2 Bio-Techne
2.2.1 Bio-Techne Details
2.2.2 Bio-Techne Major Business
2.2.3 Bio-Techne Recombinant Human PDGF-BB Protein Product and Services
2.2.4 Bio-Techne Recombinant Human PDGF-BB Protein Sales Quantity, Average Price, Revenue, Gross Margin and Âé¶¹Ô´´ Share (2020-2025)
2.2.5 Bio-Techne Recent Developments/Updates
2.3 Scientists Helping Scientists
2.3.1 Scientists Helping Scientists Details
2.3.2 Scientists Helping Scientists Major Business
2.3.3 Scientists Helping Scientists Recombinant Human PDGF-BB Protein Product and Services
2.3.4 Scientists Helping Scientists Recombinant Human PDGF-BB Protein Sales Quantity, Average Price, Revenue, Gross Margin and Âé¶¹Ô´´ Share (2020-2025)
2.3.5 Scientists Helping Scientists Recent Developments/Updates
2.4 Abcam Limited
2.4.1 Abcam Limited Details
2.4.2 Abcam Limited Major Business
2.4.3 Abcam Limited Recombinant Human PDGF-BB Protein Product and Services
2.4.4 Abcam Limited Recombinant Human PDGF-BB Protein Sales Quantity, Average Price, Revenue, Gross Margin and Âé¶¹Ô´´ Share (2020-2025)
2.4.5 Abcam Limited Recent Developments/Updates
2.5 FUJIFILM Irvine Scientific
2.5.1 FUJIFILM Irvine Scientific Details
2.5.2 FUJIFILM Irvine Scientific Major Business
2.5.3 FUJIFILM Irvine Scientific Recombinant Human PDGF-BB Protein Product and Services
2.5.4 FUJIFILM Irvine Scientific Recombinant Human PDGF-BB Protein Sales Quantity, Average Price, Revenue, Gross Margin and Âé¶¹Ô´´ Share (2020-2025)
2.5.5 FUJIFILM Irvine Scientific Recent Developments/Updates
2.6 BD Biosciences
2.6.1 BD Biosciences Details
2.6.2 BD Biosciences Major Business
2.6.3 BD Biosciences Recombinant Human PDGF-BB Protein Product and Services
2.6.4 BD Biosciences Recombinant Human PDGF-BB Protein Sales Quantity, Average Price, Revenue, Gross Margin and Âé¶¹Ô´´ Share (2020-2025)
2.6.5 BD Biosciences Recent Developments/Updates
2.7 Bio-Rad Laboratories, Inc.
2.7.1 Bio-Rad Laboratories, Inc. Details
2.7.2 Bio-Rad Laboratories, Inc. Major Business
2.7.3 Bio-Rad Laboratories, Inc. Recombinant Human PDGF-BB Protein Product and Services
2.7.4 Bio-Rad Laboratories, Inc. Recombinant Human PDGF-BB Protein Sales Quantity, Average Price, Revenue, Gross Margin and Âé¶¹Ô´´ Share (2020-2025)
2.7.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
2.8 BPS Bioscience, Inc.
2.8.1 BPS Bioscience, Inc. Details
2.8.2 BPS Bioscience, Inc. Major Business
2.8.3 BPS Bioscience, Inc. Recombinant Human PDGF-BB Protein Product and Services
2.8.4 BPS Bioscience, Inc. Recombinant Human PDGF-BB Protein Sales Quantity, Average Price, Revenue, Gross Margin and Âé¶¹Ô´´ Share (2020-2025)
2.8.5 BPS Bioscience, Inc. Recent Developments/Updates
2.9 Elabscience
2.9.1 Elabscience Details
2.9.2 Elabscience Major Business
2.9.3 Elabscience Recombinant Human PDGF-BB Protein Product and Services
2.9.4 Elabscience Recombinant Human PDGF-BB Protein Sales Quantity, Average Price, Revenue, Gross Margin and Âé¶¹Ô´´ Share (2020-2025)
2.9.5 Elabscience Recent Developments/Updates
2.10 Yisheng Biotechnology (Shanghai) Co., Ltd.
2.10.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Details
2.10.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Major Business
2.10.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human PDGF-BB Protein Product and Services
2.10.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human PDGF-BB Protein Sales Quantity, Average Price, Revenue, Gross Margin and Âé¶¹Ô´´ Share (2020-2025)
2.10.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Developments/Updates
2.11 Abbkine
2.11.1 Abbkine Details
2.11.2 Abbkine Major Business
2.11.3 Abbkine Recombinant Human PDGF-BB Protein Product and Services
2.11.4 Abbkine Recombinant Human PDGF-BB Protein Sales Quantity, Average Price, Revenue, Gross Margin and Âé¶¹Ô´´ Share (2020-2025)
2.11.5 Abbkine Recent Developments/Updates
2.12 Beijing Biocreative Technology Co., Ltd.
2.12.1 Beijing Biocreative Technology Co., Ltd. Details
2.12.2 Beijing Biocreative Technology Co., Ltd. Major Business
2.12.3 Beijing Biocreative Technology Co., Ltd. Recombinant Human PDGF-BB Protein Product and Services
2.12.4 Beijing Biocreative Technology Co., Ltd. Recombinant Human PDGF-BB Protein Sales Quantity, Average Price, Revenue, Gross Margin and Âé¶¹Ô´´ Share (2020-2025)
2.12.5 Beijing Biocreative Technology Co., Ltd. Recent Developments/Updates
2.13 Shanghai Yaji Biotechnology Co., Ltd.
2.13.1 Shanghai Yaji Biotechnology Co., Ltd. Details
2.13.2 Shanghai Yaji Biotechnology Co., Ltd. Major Business
2.13.3 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human PDGF-BB Protein Product and Services
2.13.4 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human PDGF-BB Protein Sales Quantity, Average Price, Revenue, Gross Margin and Âé¶¹Ô´´ Share (2020-2025)
2.13.5 Shanghai Yaji Biotechnology Co., Ltd. Recent Developments/Updates
2.14 Cellverse Co., Ltd.
2.14.1 Cellverse Co., Ltd. Details
2.14.2 Cellverse Co., Ltd. Major Business
2.14.3 Cellverse Co., Ltd. Recombinant Human PDGF-BB Protein Product and Services
2.14.4 Cellverse Co., Ltd. Recombinant Human PDGF-BB Protein Sales Quantity, Average Price, Revenue, Gross Margin and Âé¶¹Ô´´ Share (2020-2025)
2.14.5 Cellverse Co., Ltd. Recent Developments/Updates
2.15 Dalian Meilun Biotech Co., Ltd.
2.15.1 Dalian Meilun Biotech Co., Ltd. Details
2.15.2 Dalian Meilun Biotech Co., Ltd. Major Business
2.15.3 Dalian Meilun Biotech Co., Ltd. Recombinant Human PDGF-BB Protein Product and Services
2.15.4 Dalian Meilun Biotech Co., Ltd. Recombinant Human PDGF-BB Protein Sales Quantity, Average Price, Revenue, Gross Margin and Âé¶¹Ô´´ Share (2020-2025)
2.15.5 Dalian Meilun Biotech Co., Ltd. Recent Developments/Updates
2.16 Sino Biological,Inc.
2.16.1 Sino Biological,Inc. Details
2.16.2 Sino Biological,Inc. Major Business
2.16.3 Sino Biological,Inc. Recombinant Human PDGF-BB Protein Product and Services
2.16.4 Sino Biological,Inc. Recombinant Human PDGF-BB Protein Sales Quantity, Average Price, Revenue, Gross Margin and Âé¶¹Ô´´ Share (2020-2025)
2.16.5 Sino Biological,Inc. Recent Developments/Updates
2.17 Prospec-Tany Technogene Ltd
2.17.1 Prospec-Tany Technogene Ltd Details
2.17.2 Prospec-Tany Technogene Ltd Major Business
2.17.3 Prospec-Tany Technogene Ltd Recombinant Human PDGF-BB Protein Product and Services
2.17.4 Prospec-Tany Technogene Ltd Recombinant Human PDGF-BB Protein Sales Quantity, Average Price, Revenue, Gross Margin and Âé¶¹Ô´´ Share (2020-2025)
2.17.5 Prospec-Tany Technogene Ltd Recent Developments/Updates
2.18 ENZO
2.18.1 ENZO Details
2.18.2 ENZO Major Business
2.18.3 ENZO Recombinant Human PDGF-BB Protein Product and Services
2.18.4 ENZO Recombinant Human PDGF-BB Protein Sales Quantity, Average Price, Revenue, Gross Margin and Âé¶¹Ô´´ Share (2020-2025)
2.18.5 ENZO Recent Developments/Updates
3 Competitive Environment: Recombinant Human PDGF-BB Protein by Manufacturer
3.1 Global Recombinant Human PDGF-BB Protein Sales Quantity by Manufacturer (2020-2025)
3.2 Global Recombinant Human PDGF-BB Protein Revenue by Manufacturer (2020-2025)
3.3 Global Recombinant Human PDGF-BB Protein Average Price by Manufacturer (2020-2025)
3.4 Âé¶¹Ô´´ Share Analysis (2024)
3.4.1 Producer Shipments of Recombinant Human PDGF-BB Protein by Manufacturer Revenue ($MM) and Âé¶¹Ô´´ Share (%): 2024
3.4.2 Top 3 Recombinant Human PDGF-BB Protein Manufacturer Âé¶¹Ô´´ Share in 2024
3.4.3 Top 6 Recombinant Human PDGF-BB Protein Manufacturer Âé¶¹Ô´´ Share in 2024
3.5 Recombinant Human PDGF-BB Protein Âé¶¹Ô´´: Overall Company Footprint Analysis
3.5.1 Recombinant Human PDGF-BB Protein Âé¶¹Ô´´: Region Footprint
3.5.2 Recombinant Human PDGF-BB Protein Âé¶¹Ô´´: Company Product Type Footprint
3.5.3 Recombinant Human PDGF-BB Protein Âé¶¹Ô´´: Company Product Application Footprint
3.6 New Âé¶¹Ô´´ Entrants and Barriers to Âé¶¹Ô´´ Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Recombinant Human PDGF-BB Protein Âé¶¹Ô´´ Size by Region
4.1.1 Global Recombinant Human PDGF-BB Protein Sales Quantity by Region (2020-2031)
4.1.2 Global Recombinant Human PDGF-BB Protein Consumption Value by Region (2020-2031)
4.1.3 Global Recombinant Human PDGF-BB Protein Average Price by Region (2020-2031)
4.2 North America Recombinant Human PDGF-BB Protein Consumption Value (2020-2031)
4.3 Europe Recombinant Human PDGF-BB Protein Consumption Value (2020-2031)
4.4 Asia-Pacific Recombinant Human PDGF-BB Protein Consumption Value (2020-2031)
4.5 South America Recombinant Human PDGF-BB Protein Consumption Value (2020-2031)
4.6 Middle East & Africa Recombinant Human PDGF-BB Protein Consumption Value (2020-2031)
5 Âé¶¹Ô´´ Segment by Type
5.1 Global Recombinant Human PDGF-BB Protein Sales Quantity by Type (2020-2031)
5.2 Global Recombinant Human PDGF-BB Protein Consumption Value by Type (2020-2031)
5.3 Global Recombinant Human PDGF-BB Protein Average Price by Type (2020-2031)
6 Âé¶¹Ô´´ Segment by Application
6.1 Global Recombinant Human PDGF-BB Protein Sales Quantity by Application (2020-2031)
6.2 Global Recombinant Human PDGF-BB Protein Consumption Value by Application (2020-2031)
6.3 Global Recombinant Human PDGF-BB Protein Average Price by Application (2020-2031)
7 North America
7.1 North America Recombinant Human PDGF-BB Protein Sales Quantity by Type (2020-2031)
7.2 North America Recombinant Human PDGF-BB Protein Sales Quantity by Application (2020-2031)
7.3 North America Recombinant Human PDGF-BB Protein Âé¶¹Ô´´ Size by Country
7.3.1 North America Recombinant Human PDGF-BB Protein Sales Quantity by Country (2020-2031)
7.3.2 North America Recombinant Human PDGF-BB Protein Consumption Value by Country (2020-2031)
7.3.3 United States Âé¶¹Ô´´ Size and Forecast (2020-2031)
7.3.4 Canada Âé¶¹Ô´´ Size and Forecast (2020-2031)
7.3.5 Mexico Âé¶¹Ô´´ Size and Forecast (2020-2031)
8 Europe
8.1 Europe Recombinant Human PDGF-BB Protein Sales Quantity by Type (2020-2031)
8.2 Europe Recombinant Human PDGF-BB Protein Sales Quantity by Application (2020-2031)
8.3 Europe Recombinant Human PDGF-BB Protein Âé¶¹Ô´´ Size by Country
8.3.1 Europe Recombinant Human PDGF-BB Protein Sales Quantity by Country (2020-2031)
8.3.2 Europe Recombinant Human PDGF-BB Protein Consumption Value by Country (2020-2031)
8.3.3 Germany Âé¶¹Ô´´ Size and Forecast (2020-2031)
8.3.4 France Âé¶¹Ô´´ Size and Forecast (2020-2031)
8.3.5 United Kingdom Âé¶¹Ô´´ Size and Forecast (2020-2031)
8.3.6 Russia Âé¶¹Ô´´ Size and Forecast (2020-2031)
8.3.7 Italy Âé¶¹Ô´´ Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Recombinant Human PDGF-BB Protein Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Recombinant Human PDGF-BB Protein Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Recombinant Human PDGF-BB Protein Âé¶¹Ô´´ Size by Region
9.3.1 Asia-Pacific Recombinant Human PDGF-BB Protein Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Recombinant Human PDGF-BB Protein Consumption Value by Region (2020-2031)
9.3.3 China Âé¶¹Ô´´ Size and Forecast (2020-2031)
9.3.4 Japan Âé¶¹Ô´´ Size and Forecast (2020-2031)
9.3.5 South Korea Âé¶¹Ô´´ Size and Forecast (2020-2031)
9.3.6 India Âé¶¹Ô´´ Size and Forecast (2020-2031)
9.3.7 Southeast Asia Âé¶¹Ô´´ Size and Forecast (2020-2031)
9.3.8 Australia Âé¶¹Ô´´ Size and Forecast (2020-2031)
10 South America
10.1 South America Recombinant Human PDGF-BB Protein Sales Quantity by Type (2020-2031)
10.2 South America Recombinant Human PDGF-BB Protein Sales Quantity by Application (2020-2031)
10.3 South America Recombinant Human PDGF-BB Protein Âé¶¹Ô´´ Size by Country
10.3.1 South America Recombinant Human PDGF-BB Protein Sales Quantity by Country (2020-2031)
10.3.2 South America Recombinant Human PDGF-BB Protein Consumption Value by Country (2020-2031)
10.3.3 Brazil Âé¶¹Ô´´ Size and Forecast (2020-2031)
10.3.4 Argentina Âé¶¹Ô´´ Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Recombinant Human PDGF-BB Protein Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Recombinant Human PDGF-BB Protein Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Recombinant Human PDGF-BB Protein Âé¶¹Ô´´ Size by Country
11.3.1 Middle East & Africa Recombinant Human PDGF-BB Protein Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Recombinant Human PDGF-BB Protein Consumption Value by Country (2020-2031)
11.3.3 Turkey Âé¶¹Ô´´ Size and Forecast (2020-2031)
11.3.4 Egypt Âé¶¹Ô´´ Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Âé¶¹Ô´´ Size and Forecast (2020-2031)
11.3.6 South Africa Âé¶¹Ô´´ Size and Forecast (2020-2031)
12 Âé¶¹Ô´´ Dynamics
12.1 Recombinant Human PDGF-BB Protein Âé¶¹Ô´´ Drivers
12.2 Recombinant Human PDGF-BB Protein Âé¶¹Ô´´ Restraints
12.3 Recombinant Human PDGF-BB Protein Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Recombinant Human PDGF-BB Protein and Key Manufacturers
13.2 Manufacturing Costs Percentage of Recombinant Human PDGF-BB Protein
13.3 Recombinant Human PDGF-BB Protein Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Recombinant Human PDGF-BB Protein Typical Distributors
14.3 Recombinant Human PDGF-BB Protein Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Thermo Fisher Scientific Inc.
Bio-Techne
Scientists Helping Scientists
Abcam Limited
FUJIFILM Irvine Scientific
BD Biosciences
Bio-Rad Laboratories, Inc.
BPS Bioscience, Inc.
Elabscience
Yisheng Biotechnology (Shanghai) Co., Ltd.
Abbkine
Beijing Biocreative Technology Co., Ltd.
Shanghai Yaji Biotechnology Co., Ltd.
Cellverse Co., Ltd.
Dalian Meilun Biotech Co., Ltd.
Sino Biological,Inc.
Prospec-Tany Technogene Ltd
ENZO
Ìý
Ìý
*If Applicable.